Preventing fungal disease in chronically immunosuppressed outpatients: Time for action?

Annals of Internal Medicine

Volumn 158, Issue 7, 2013, Pages 555-556

  Kontoyiannis, Dimitrios P ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRIAZOLE DERIVATIVE;

ARTICLE; ASPERGILLUS FUMIGATUS; ASPERGILLUS TERREUS; DISEASE SEVERITY; EXSEROHILUM ROSTRATUM; FUNGAL MENINGITIS; FUNGAL STRAIN; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HEALTH CARE POLICY; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNE DEFICIENCY; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNOPROPHYLAXIS; INFECTION CONTROL; INFECTION RISK; MYCOSIS; OUTPATIENT CARE; PHYSICIAN; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; STEM CELL TRANSPLANTATION;

ANTIFUNGAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSION; INFECTION CONTROL; MYCOSES; OUTPATIENTS;

EID: 84875718407     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-158-7-201304020-00007     Document Type: Article

References (10)

1. Bieri S, Roosnek E, Ozsahin H, Huguet S, Ansari M, Trombetti A, et al. Outcome and risk factors for late-onset complications 24 months beyond alloge-neic hematopoietic stem cell transplantation. Eur J Haematol. 2011;87:138-47.
2. Kontoyiannis DP. Antifungal prophylaxis in hematopoietic stem cell trans-plant recipients: the unfinished tale of imperfect success. Bone Marrow Trans-plant. 2011;46:165-73.
3. Partridge-Hinckley K, Liddell GM, Almyroudis NG, Segal BH. Infection control measures to prevent invasive mould diseases in hematopoietic stem cell transplant recipients. Mycopathologia. 2009;168:329-37.
4. Centers for Disease Control and Prevention (CDC). Healthcare-associated infections: guidelines and recommendations. Accessed at www.cdc.gov/HAI/prevent/prevent_pubs.html on 2 January 2013.
5. Centers for Disease Control and Prevention (CDC). Healthcare-associated infections: basic infection control and prevention plan for outpatient oncology settings. Accessed at www.cdc.gov/HAI/settings/outpatient/basic-infection-control-prevention-plan-2011/ on 5 February 2013.
6. Sipsas NV, Kontoyiannis DP. Occupation, lifestyle, diet, and invasive fungal infections. Infection. 2008;36:515-25.
7. Lass-Flörl C, Grif K, Kontoyiannis DP. Molecular typing of Aspergillus terreus isolates collected in Houston, Texas, and Innsbruck, Austria: evidence of great genetic diversity. J Clin Microbiol. 2007;45:2686-90.
8. Raad I, Tarrand J, Hanna H, Albitar M, Janssen E, Boktour M, et al. Epidemiology, molecular mycology, and environmental sources of Fusarium in-fection in patients with cancer. Infect Control Hosp Epidemiol. 2002;23:532-7.
9. Panackal AA, Li H, Kontoyiannis DP, Mori M, Perego CA, Boeckh M, et al. Geoclimatic influences on invasive aspergillosis after hematopoietic stem cell transplantation. Clin Infect Dis. 2010;50:1588-97.
10. Warris A, Onken A, Gaustad P, Janssen W, van der Lee H, Verweij PE, et al. Point-of-use filtration method for the prevention of fungal contamination of hospital water. J Hosp Infect. 2010;76:56-9.